Francoise Grude
Saint-denis-de-palin, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.
Journal: International journal of cancer
Published: November 16, 2021
Knowledge of geriatric oncology in nursing homes: survey among healthcare professionals working in nursing homes in Pays-de-la-Loire.
Journal: Geriatrie et psychologie neuropsychiatrie du vieillissement
Published: May 31, 2021
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 25, 2020
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: November 10, 2020
Evaluation of Clinical Trials in Onco-haematology: A New Method Based on Risk Analysis and Multidisciplinarity.
Journal: Therapeutic innovation & regulatory science
Published: June 29, 2020
Management of cancer patients with oral therapy at home in Brittany and Pays de la Loire areas: Survey (end of 2016) and cartography
Journal: Bulletin du cancer
Published: January 31, 2019
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Journal: International journal of cancer
Published: January 16, 2019
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 20, 2016
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne / Pays de la Loire).
Journal: Oncologie (Paris, France)
Published: October 17, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026